The deleterious effects of hypoxia are too well known to physiologists, clinicians and flight surgeons to require emphasis, and the efficacy of the inhalation of air rich in oxygen to overcome hypoxia and prevent or correct its harmful action is equally well known. The use of oxygen therapy in...
This study expands the understanding of congruence, or the level of agreement, between therapists and patients regarding therapy progress perception during
Temporal lobe epilepsy (TLE), exemplified by complex partial seizures, is recognized in ~30% of epileptic patients. Seizures in TLE are associated with cog
Business Health note patient Nursing Nursing Note Templates Samples Examples Neg Nursing Note Sample Nursing Note Example More info CommentsHow to write a Nursing Note? Download this Nursing Home Progress Note template that will perfectly suit your needs. Our collection of online health templates aims...
the FDA approved Pembrolizumab to treat patients with advanced PD-L1 expressing NSCLC whose disease had worsened following chemotherapy in October 2015. Again, in the phase III KEYNOTE-024 trial (NCT02142738) that assessed the effectiveness of Pembrolizumab as first-line therapy compared to different...
We're also using sacituzumab govitecan in patients with metastatic disease. That's an example of a more targeted chemotherapy approach. There's also targeted therapy like olaparib [Lynparza], which [could be used in select patients] either after surgery or sometimes in the metastatic setting....
Animal models have been instrumental in preclinical investigation in radiation therapy, as in many other domains of oncology research. For example, the advantages of dose fractionation were discovered using rams more than a century ago [124]. More recently, rodent models have provided significant insi...
(“FDA”) has granted Fast Track designation for the proposed use of ivonescimab in combination with platinum-based chemotherapy for the treatment of adult patients with locally advanced or metastatic NSCLC with EGFR mutation, who have experienced disease progression following EGFR-TKI...
Colorectal cancer (CRC) is a common malignant tumor with the third and second highest incidence and mortality rates among various malignant tumors. Despite significant advancements in the present therapy for CRC, the majority of CRC cases feature profici
Protein kinases regulate nearly all aspects of cell life, and alterations in their expression, or mutations in their genes, cause cancer and other diseases. Here, we review the remarkable progress made over the past 20 years in improving the potency and